Opportunity ID: 323103

General Information

Document Type: Grants Notice
Funding Opportunity Number: RFA-MH-20-330
Funding Opportunity Title: Novel Imaging Approaches for detection of Persistent HIV and Neuroimmune dysfunction associated with HIV In the Central Nervous System (CNS) (R01 Clinical Trial Optional)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.242 — Mental Health Research Grants
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Dec 16, 2019
Last Updated Date: Dec 16, 2019
Original Closing Date for Applications: Mar 11, 2020
Current Closing Date for Applications: Mar 11, 2020
Archive Date: Apr 16, 2020
Estimated Total Program Funding:
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: State governments
Native American tribal organizations (other than Federally recognized tribal governments)
City or township governments
Special district governments
Public and State controlled institutions of higher education
County governments
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Small businesses
Private institutions of higher education
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Native American tribal governments (Federally recognized)
Public housing authorities/Indian housing authorities
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Independent school districts
For profit organizations other than small businesses
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Additional Information

Agency Name: National Institutes of Health
Description: This Funding Opportunity Announcement (FOA) invites research applications to elucidate mechanisms of neuroimmune dysfunction caused by HIV-1 and to detect persistent/latent/reactivated HIV using novel imaging/neuroimaging approaches in the central nervous system from anti-retroviral therapy (ART) suppressed individuals. Applications testing a fully conceptualized and hypothesis-based solid premise founded with adequate preliminary data should consider applying to the companion R21 announcement, RFA MH-20-331 . Basic and preclinical research in domestic and international settings are of interest. Multidisciplinary research teams and collaborative alliances are encouraged but not required.
Link to Additional Information: http://grants.nih.gov/grants/guide/rfa-files/RFA-MH-20-330.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV
Email:FBOWebmaster@OD.NIH.GOV

Version History

Version Modification Description Updated Date

Related Documents

Packages

Agency Contact Information: NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV
Email: FBOWebmaster@OD.NIH.GOV
Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
FORMS-F Use for due dates on or after May 25, 2020 PKG00259311 Feb 11, 2020 Mar 11, 2020 View
FORMS-E Use for due dates on or before May 24, 2020 PKG00257161 Feb 11, 2020 May 24, 2020 View

Package 1

Mandatory forms

323103 RR_SF424_2_0-2.0.pdf

323103 PHS398_CoverPageSupplement_5_0-5.0.pdf

323103 RR_OtherProjectInfo_1_4-1.4.pdf

323103 PerformanceSite_2_0-2.0.pdf

323103 RR_KeyPersonExpanded_2_0-2.0.pdf

323103 PHS398_ResearchPlan_4_0-4.0.pdf

323103 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf

Optional forms

323103 RR_Budget_1_4-1.4.pdf

323103 RR_SubawardBudget30_1_4-1.4.pdf

323103 PHS398_ModularBudget_1_2-1.2.pdf

323103 PHS_AssignmentRequestForm_3_0-3.0.pdf

Package 2

Mandatory forms

323103 RR_SF424_2_0-2.0.pdf

323103 PHS398_CoverPageSupplement_4_0-4.0.pdf

323103 RR_OtherProjectInfo_1_4-1.4.pdf

323103 PerformanceSite_2_0-2.0.pdf

323103 RR_KeyPersonExpanded_2_0-2.0.pdf

323103 PHS398_ResearchPlan_4_0-4.0.pdf

Optional forms

323103 RR_Budget_1_4-1.4.pdf

323103 RR_SubawardBudget30_1_4-1.4.pdf

323103 PHS398_ModularBudget_1_2-1.2.pdf

323103 PHS_AssignmentRequestForm_2_0-2.0.pdf

2025-07-09T11:40:13-05:00

Share This Post, Choose Your Platform!

About the Author: